Success Story: Iranian Researcher Earns NIW Approval for Advancing Women’s Health and Cancer Prevention

Client’s Testimonial:

“I’m deeply grateful for the professional guidance and support throughout my NIW journey. Their expertise made the entire process smooth and successful.”

On October 16^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Researcher in the field of Gynecologic Oncology (Approval Notice).

General Field: Gynecologic Oncology

Position at the Time of Case Filing: Researcher

Country of Origin: Iran

Country of Residence at the Time of Filing: Iran

Approval Notice Date: October 16^th, 2025

Processing Time: 1 year, 6 months, 1 day

Case Summary:

We are pleased to share the NIW approval of a researcher from Iran whose work advances women’s health through improved prevention, diagnosis, and treatment of gynecologic cancers. At the time of filing, she was conducting research that bridges clinical medicine and public health, with the goal of reducing cancer mortality and improving evidence-based healthcare policy. With a strong record of publications, citations, and expert endorsements, she presented an exceptional case for NIW approval.

Research with National Importance

The client’s research focuses on gynecologic cancers, including cervical, ovarian, and vulvar cancers, to identify risk factors and optimize clinical outcomes. Her findings inform treatment strategies and preventive care policies that support early detection and equitable access to women’s healthcare. As these diseases remain a leading cause of mortality among American women, her work directly aligns with U.S. public health priorities in cancer prevention and women’s wellness.

Academic Achievements and Recognition

The client holds an M.D. specializing in gynecologic oncology and has authored 15 peer-reviewed journal articles and one conference abstract in leading outlets such as Psychology, Health & Medicine, Indian Pediatrics, and the Iranian Journal of Reproductive Medicine. Her research has been cited 153 times by independent scholars, with two papers ranking among the top 20% most cited in Clinical Medicine. Her studies on ectopic pregnancy, intimate partner violence, and vulvar cancer epidemiology have informed both clinical practice and medical research, underscoring her impact in women’s health.

Expert Endorsements

Independent experts praised her scientific and clinical contributions.

One recommender wrote:

“The United States must recognize and support [client]’s research, as she is an invaluable medical research community member with a steady history of achievement and valuable contribution to our field.”

This statement underscores her long-standing commitment to advancing women’s health and her continued value to the U.S. medical research community.

NIW Approval and Outlook

The I-140 NIW petition was filed on April 15, 2024, received an RFE on March 4, 2025, and was approved on October 16, 2025. USCIS recognized her publication record, citation impact, and the national significance of her work as meeting the NIW standard.

With NAILG’s support, the client achieved NIW approval and continues her efforts to expand access to equitable, evidence-based care for women worldwide. Her ongoing research will strengthen U.S. healthcare innovation and reinforce leadership in gynecologic oncology and women’s health.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.